Healio

Long-term data support success of CyberKnife technology for neurosurgery

In a company release, Accuray Inc. announced its CyberKnife radiotherapy platform, which delivers stereotactic radiosurgery to treat lesions in the brain, was supported by more than 2 decades of ...
Nasdaq

10-Year Data Shows Accuray CyberKnife® System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia

SUNNYVALE, Calif., March 31, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that long-term follow-up data from a study of men and women with trigeminal neuralgia (TN) showed ...
Yahoo Finance

CyberKnife Market Worth $560M in 2025 is Set to Reach $2.71 Billion by 2032: Shaping the Next Phase of Precision Radiotherapy

Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "Cyberknife Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The CyberKnife market is redefining precision ...
Nasdaq

Data Published in The Lancet Oncology Suggest CyberKnife® Prostate Patients Experienced Lower Levels of Acute Genitourinary Toxicity (Grade 2 or Higher) Than Patients Treated ...

SUNNYVALE, Calif., Sept. 17, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announces that The Lancet Oncology, a high impact and leading global peer-reviewed oncology journal, has published ...
MyCentralJersey

CyberKnife® Radiosurgery

The CyberKnife® Robotic Radiosurgery System at Saint Peter‘s University Hospital is a pain-free, noninvasive alternative to surgery that can effectively treat complex tumors located virtually anywhere ...
Medscape

Cyberknife Surgery Another Option for Trigeminal Neuralgia

February 8, 2012 — Cyberknife radiosurgery to relieve trigeminal neuralgia refractory to medical management is a promising, viable alternative to more invasive treatment for this painful condition, ...